On November 28th, the "National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug Catalog (2024)" was officially announced. Sanofi's three innovative drugs are among them, including Dabitou& reg; (Dupilumab injection) successfully renewed contract, Yilaike& reg; (Besudil Methanesulfonate Tablets) and Zhilida& reg; Rosuvastatin ezetimibe tablets (I) have been included in the medical insurance catalog for the first time. The revised version of the medical insurance drug catalog will be officially implemented from January 1, 2025.